Insights from the 2025 Honeywell Life Sciences World Tour Axendia participated in the Honeywell Life Sciences World Tour USA. Under the theme “Innovation for a […]
Accelerating Innovation for a Healthier Future Read More »
MasterControl Briefing Note Axendia was briefed by Matt Lowe, Chief Strategy Officer at MasterControl on its acquisition of Qualer. Founded in 2018 by a calibration
Asset Excellence as a Force Multiplier Read More »
The FDA is embarking on a transformative journey—one that seeks to modernize regulatory processes, accelerate approvals, and address chronic disease trends in a proactive manner.
Commissioner Unveils Priorities for a New FDA Read More »
HighByte Briefing Note Axendia was briefed by Torey Penrod-Cambra, Co-Founder & Chief Communications Officer, and Jeffrey Schroeder, Product Manager, at HighByte, a software company that was founded in
Moving Data with Purpose to Drive Value Read More »
An Axendia “Straight from the Source” Episode In the debut episode of Straight from the Source, Axendia’s President Daniel R. Matlis and Senior Industry Analyst, Sandra
The Impact of the Most Favored Nation Pricing Executive Order Read More »
An Apprentice.io Briefing Note Axendia was briefed by the executive team at Apprentice.io, including Angelo Stracquatanio, CEO and Co-Founder, Emilee Cook, VP of Product, Justin
The Expanding Role of Agentic AI Connected Manufacturing Read More »
ComplianceQuest ConQuest 2025 Event Brief ComplianceQuest held its second annual user conference (ConQuest 2025) in Clearwater, FL from 8-10 April 2025. This year’s theme was
Where Compliance Meets Innovation: A New Chapter Unfolds at ConQuest Read More »
On May 8, 2025, the U.S. Food and Drug Administration (FDA) announced a historic milestone: the completion of its first AI-assisted scientific review pilot. Additionally,
From Pilot to Policy: FDA’s AI Transformation Hits Fast Forward Read More »
On May 5, 2025, an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines“ was signed by the administration. The order seeks
Strengthening Domestic Pharmaceutical Manufacturing in the Age of Continuous Disruption Read More »
Stellix Aspire 2025 Event Brief Axendia was pleased to be invited to cover Stellix Aspire 2025, an exclusive event where thought leaders and executives gathered to advance
Innovation, Collaboration, Acceleration Read More »
ETQ Briefing Note Axendia was recently briefed by the executive team at ETQ, part of Hexagon, including Chris Nahil, Analyst Relations, Maureen Pienta, CMO and
Empowering Quality-Driven Innovation Read More »
Insights from Nanoprecise’s Briefing Nanoprecise leadership, including Kevin Clark, Chief Evangelist Officer, Param Desai, Chief Product Officer, and Jeffrey Hill, Director of Life Sciences, recently shared their perspective on
